# Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-commonly-drug-leukemia-cells-early.html) · 2026-11-20 · Medicine
Page: https://themorning.science/story/commonly-used-drug-kills-leukemia-cells-early-by-acting-mainly-on-rna-not-dna-19bf635fd8313e8b
Kind: research · Impact: medium

## In brief

- A commonly used drug, azacitidine, has been a major treatment for high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) for more than two decades.
- The drug was long thought to work through DNA by stripping off chemical tags that keep genes silenced.
- A new report says azacitidine kills leukemia cells early mainly by acting on RNA rather than DNA.

## Why it matters

Identifying RNA rather than DNA as the main target of a widely used leukemia drug changes how its mechanism is understood, which could inform future treatment design.

## Coverage

- [Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA](https://medicalxpress.com/news/2026-11-commonly-drug-leukemia-cells-early.html) — Medical Xpress - latest medical and health news stories, 2026-11-20

Tags: azacitidine, leukemia, rna, dna, cancer-research

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
